Brenus Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Brenus Pharma's estimated annual revenue is currently $3.4M per year.
- Brenus Pharma's estimated revenue per employee is $155,000
- Brenus Pharma's total funding is $30M.
Employee Data
- Brenus Pharma has 22 Employees.
- Brenus Pharma grew their employee count by 22% last year.
Brenus Pharma's People
| Name | Title | Email/Phone |
|---|
Brenus Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 63 | 133% | $22.9M | N/A |
#2 | $15.7M | 101 | 25% | N/A | N/A |
#3 | $35.5M | 229 | 21% | N/A | N/A |
#4 | $13.6M | 88 | 69% | N/A | N/A |
#5 | $17.2M | 111 | 25% | N/A | N/A |
#6 | $7.6M | 49 | 7% | $71.8M | N/A |
#7 | $5.1M | 33 | 0% | $24.6M | N/A |
#8 | $1.1M | 7 | N/A | N/A | N/A |
#9 | $3.4M | 22 | 22% | $30M | N/A |
#10 | $3.6M | 23 | 44% | $5.55M | N/A |
What Is Brenus Pharma?
Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.\n\nWe developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform. \n\nOur lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide.\n\n\t- Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies) \n\n\t- We overcome limitations of several technologies such as mRNA vaccines thanks to our enhanced immunogenicity and standardized GMP manufacturing: we keep control of costs and supply. \n\nAwarded “Best Biotech Startup” in 2024 in France, we recently closed a $25M SERIES A to accelerate our clinical development.\n\nWe are currently envisaging clinical collaborations.\n\nBrenus Pharma sets a new paradigm in oncology, by giving back to patients the ability to fight against their disease.
keywords:N/A
$30M
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Lyon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 22 | 10% | N/A |
#2 | $2.3M | 23 | -18% | N/A |
#3 | $2.3M | 23 | -61% | N/A |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $3.5M | 25 | 25% | N/A |